MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 1751-1760 Newer>
The Motley Fool
February 8, 2005
Charly Travers
Investing in a Cure Drugs in the pipeline offer potential breakthroughs for Alzheimer's disease. Instead of investing in small biotechs that have a lot riding on a single Alzheimer's program, the best way to invest in the field is through a diversified company mark for My Articles 307 similar articles
The Motley Fool
February 8, 2005
Stephen D. Simpson
Cyberonics Looks to the Future Shifting resources to the launch of a depression therapy will hurt now, but should pay off later. Investors looking to take on some risk in exchange for an aggressive growth opportunity might want to explore this one. mark for My Articles 56 similar articles
The Motley Fool
February 8, 2005
Stephen D. Simpson
Kyphon Developing a Backbone The small med-tech company posts a rich valuation, but growth is hot, and the market is huge. mark for My Articles 30 similar articles
The Motley Fool
February 8, 2005
Stephen D. Simpson
Lincare Needs Some Air Will cuts in government reimbursement leave this home oxygen company short of breath? Investors who already own these shares might just want to hang on -- Lincare has been through this before mark for My Articles 8 similar articles
The Motley Fool
February 7, 2005
Stephen D. Simpson
Axonyx Gets Crushed The biotech company is hammered by disappointing phase 3 results of an Alzheimer's drug. mark for My Articles 113 similar articles
The Motley Fool
February 7, 2005
Brian Gorman
Alkermes Is Coming of Age The drug delivery company may soon have its own drug on the market. mark for My Articles 114 similar articles
The Motley Fool
February 4, 2005
Stephen D. Simpson
Cyberonics' Depression Zapper Medical technology company gets a much-needed boost from the FDA. mark for My Articles 329 similar articles
The Motley Fool
February 4, 2005
Stephen D. Simpson
Ventana's Window to Growth Can this accelerating diagnostics company grow into its valuation? mark for My Articles 10 similar articles
Fast Company
February 2005
Jena McGregor
Fast Take: Culture At Eli Lilly, learning from past failures is a routine part of the culture. Every failed compound gets a thorough examination, which can lead to new insights, or in some cases, survival of another drug. mark for My Articles 143 similar articles
Wired
February 2005
Steve Silberman
The Painful Truth The Iraq war is a new kind of hell, with more survivors - but more maimed, shattered limbs - than ever. A revolution in battlefield medicine is helping them conquer the pain. mark for My Articles 196 similar articles
<Older 1751-1760 Newer>    Return to current articles.